share_log

Hims & Hers Health | 8-K: Current report

Hims & Hers Health | 8-K: Current report

Hims & Hers Health | 8-K:重大事件
美股SEC公告 ·  2024/07/22 13:38

Moomoo AI 已提取核心訊息

Hims & Hers Health announced the expansion of its Board of Directors from eight to nine members with the appointment of Kåre Schultz, 63, as an independent director, effective July 16, 2024. Schultz will serve until the company's 2025 annual meeting of stockholders or until his successor is elected.The Board has confirmed that Schultz meets the independence requirements under the New York Stock Exchange listing standards and the Securities Exchange Act. He will receive standard director compensation as outlined in the company's April 2024 proxy statement. Committee appointments are pending.
Hims & Hers Health announced the expansion of its Board of Directors from eight to nine members with the appointment of Kåre Schultz, 63, as an independent director, effective July 16, 2024. Schultz will serve until the company's 2025 annual meeting of stockholders or until his successor is elected.The Board has confirmed that Schultz meets the independence requirements under the New York Stock Exchange listing standards and the Securities Exchange Act. He will receive standard director compensation as outlined in the company's April 2024 proxy statement. Committee appointments are pending.
Hims & HERS Health宣佈董事會成員從八人擴展至九人,任命63歲的Kåre Schultz爲獨立董事,自2024年7月16日起生效。Schultz將服務至公司2025年股東年會或直至其繼任者當選。董事會確認Schultz符合紐約證券交易所上市標準和證券交易法下的獨立性要求。他將按照公司2024年4月的代理聲明中列出的標準董事補償進行補償。委員會的任命尚待定。
Hims & HERS Health宣佈董事會成員從八人擴展至九人,任命63歲的Kåre Schultz爲獨立董事,自2024年7月16日起生效。Schultz將服務至公司2025年股東年會或直至其繼任者當選。董事會確認Schultz符合紐約證券交易所上市標準和證券交易法下的獨立性要求。他將按照公司2024年4月的代理聲明中列出的標準董事補償進行補償。委員會的任命尚待定。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息